Overview
Emel Saglar practices in Ankara, Turkey. Saglar is rated as a Distinguished expert by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. Their top areas of expertise are Diabetes Insipidus (DI), Neurohypophyseal Diabetes Insipidus, and Nephrogenic Diabetes Insipidus.
Their clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Neurohypophyseal Diabetes Insipidus.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Diabetes Insipidus (DI)
- Distinguished
- Nephrogenic Diabetes InsipidusSaglar isDistinguished. Learn about Nephrogenic Diabetes Insipidus.
- Neurohypophyseal Diabetes InsipidusSaglar isDistinguished. Learn about Neurohypophyseal Diabetes Insipidus.